No Data
No Data
Atara Biotherapeutics' Ebvallo (Tabelecleucel) Wins Prix Galien International Award for Best Product for Orphan/Rare Diseases
Ebvallo is the First and Only Approved Therapy in Europe for Adults and Children with EBV+ PTLD Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr
Pierre Fabre Laboratories Recibe El Premio Galien International Por EBVALLO
-Pierre Fabre Laboratories recibe el Premio Galien International por EBVALLO, la primera inmunoterapia alogénica para pacientes con un cáncer raro CASTRES, Francia, 21 de junio de 2024 /PRNewswire/
Pierre Fabre Laboratories Receives the Galien International Prize for EBVALLO, the First Allogeneic Immunotherapy for Patients With a Rare Cancer
CASTRES, France, June 21, 2024 /PRNewswire/ -- Pierre Fabre Laboratories has been awarded the "Prix Galien International" Prize in the "Best Product for a Rare/Orphan Disease" category for EBVALLO (t
Investors Don't See Light At End Of Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) Tunnel And Push Stock Down 49%
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) shareholders that were waiting for something to happen have been dealt a blow with a 49% share price drop in the last month. For any long-term shareholders
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
12 Health Care Stocks Moving In Monday's Intraday Session
GainersMustang Bio (NASDAQ:MBIO) stock moved upwards by 307.9% to $0.53 during Monday's regular session. The company's market cap stands at $14.9 million. Scinai Immunotherapeutics (NASDAQ:SCNI) stock